Brief: Fibrogen Regains All Rights To Roxadustat From Astrazeneca In The United States And Other Astrazeneca Territories, Except China And South Korea

Kyntra Bio

26/02/2024 21:09

FibroGen Inc  FGEN.O :
    * FIBROGEN REGAINS ALL RIGHTS TO ROXADUSTAT FROM ASTRAZENECA
IN
THE UNITED STATES AND OTHER ASTRAZENECA TERRITORIES, EXCEPT
CHINA AND SOUTH KOREA
    * FIBROGEN INC - FIBROGEN - ASTRAZENECA CHINA AGREEMENT FOR
ROXADUSTAT REMAINS IN PLACE
    * FIBROGEN INC - FIBROGEN TO EXPLORE LICENSING OPPORTUNITIES
FOR
ROXADUSTAT
    * FIBROGEN INC - FIBROGEN AND ASTRAZENECA HAVE AGREED TO
TERMINATE
U.S./ROW ROXADUSTAT COLLABORATION AGREEMENT ENTERED INTO ON JULY
30, 2013

Source text for Eikon:  ID:nGNX1PCNs3 
Further company coverage:  FGEN.O